| Original language | English |
|---|---|
| Pages (from-to) | 1153-1155 |
| Number of pages | 3 |
| Journal | Annals of Pharmacotherapy |
| Volume | 58 |
| Issue number | 11 |
| DOIs | |
| State | Published - Nov 2024 |
Efficacy of Fluvoxamine in Outpatients With COVID-19: Understanding Conflicting Conclusions From 2 Recent Meta-Analyses of the Same Clinical Trials
Marina Sánchez-Rico, Katayoun Rezaei, Eric J. Lenze, Frédéric Limosin, Nicolas Hoertel
- Washington University School of Medicine
- Department of Psychiatry
- Institute for Public Health
- Institute of Clinical and Translational Sciences (ICTS)
- Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
- Hope Center for Neurological Disorders
- Intellectual and Developmental Disabilities Research Center (IDDRC)
- COVID-19 Researchers
Research output: Contribution to journal › Letter › peer-review
3
Scopus
citations